Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST)
NCT02330029 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2016-11-22
Summary
The purpose of this study is to test the onset of action, offset of action, efficacy, and safety of pinaverium and an herbal medication for irritable bowel syndrome (IBS) for a long term (over one year). Pinaverium has been in many countries, but there is no randomized, double-blind, large sample size, and placebo-controlled study on this medication yet. Tong Xie Yao Fang (Formula for pain and diarrhea) is a historically and contemporarily used traditional Chinese medicine that can be used for IBS. The hypothesis is that the two remedies are effective and safe for IBS treatment with no significant different onset and offset of actions when tested by modern clinical standards and criteria.
Conditions
- Irritable Bowel Syndrome
Interventions
- DRUG
-
Pinaverium
To test the effectiveness and safety of the formula for pain and diarrhea, we will randomly assign patients into one 3 groups: Pinaverium, TCM (Formula for pain and diarrhea) group, and placebo group, and treat them accordingly.
- DEVICE
-
Atractylodes
Atractylodes (\~10-15g)
- DEVICE
-
Paeonia Lactiflora
Paeonia Lactiflora (\~15-30g)
- DEVICE
-
Tangerine Peel
Tangerine Peel (\~10g)
- DRUG
-
Ledebouriella Root
Ledebouriella Root (\~10g)
- DRUG
-
Radix codonopsitis
Radix codonopsitis (\~10-15g)
- DRUG
-
Radix curcumae
Radix curcumae (\~10g)
- DRUG
-
Fingered citron
Fingered citron (\~10g)
- DRUG
-
Tuckahoe
Tuckahoe (15g)
- DRUG
-
Placebo is blindly given to patients.
Sponsors & Collaborators
-
Macrohard Institute of Health
lead OTHER
Principal Investigators
-
Baiwen Li, MD · Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao Tong University, 100 Haining Rd. Hongkou, Shanghai 200280, China.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2014-11-30
- Completion
- 2017-05-31
Countries
- China
Study Locations
More Related Trials
-
Diarrhea Predominant Irritable Bowel Syndrome in Females
NCT00461526 ·Status: COMPLETED ·Phase: PHASE2
-
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
NCT01722318 ·Status: COMPLETED ·Phase: PHASE2
-
Fibre and Gas in Irritable Bowel Syndrome
NCT03265002 ·Status: COMPLETED ·Phase: NA
-
Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
NCT05990764 ·Status: RECRUITING ·Phase: NA
-
Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome
NCT06032117 ·Status: COMPLETED
-
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
NCT05064930 ·Status: COMPLETED ·Phase: NA
-
Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome
NCT02270268 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel Syndrome
NCT04808271 ·Status: COMPLETED ·Phase: NA
-
Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?
NCT00189033 ·Status: COMPLETED ·Phase: NA
-
Effects of Open-label vs Double-blind Treatment in IBS
NCT02802241 ·Status: COMPLETED ·Phase: NA
-
A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)
NCT00394186 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
NCT03300804 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome
NCT00135031 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid
NCT01449487 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients
NCT01370720 ·Status: UNKNOWN ·Phase: PHASE2
-
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
NCT04217733 ·Status: RECRUITING ·Phase: PHASE3
-
Transcranial Magnetic Stimulation and Pharmacologic/Probiotic Interventions for Diarrhea-Predominant IBS
NCT07172139 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS)
NCT00844961 ·Status: COMPLETED ·Phase: NA
-
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
NCT01736423 ·Status: COMPLETED ·Phase: PHASE3
-
Internet-delivered Exposure-based Cognitive Behavior Therapy for Irritable Bowel Syndrome - a Cohort Effectiveness Study
NCT05328245 ·Status: COMPLETED
-
To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome
NCT04950296 ·Status: COMPLETED ·Phase: NA
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
NCT03729271 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT05509725 ·Status: RECRUITING ·Phase: PHASE4